Leidos
- Market cap
- 14.25B
- P/E (TTM)i
- 10.60
- P/Bi
- 2.70
- EPSi
- 11.14
- Div yieldi
- 1.49%
- 52W posi
- 14%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.2 percentage points.
Institutional ownership
- Held by institutions
- 81.02% -0.20pp
- Institutions
- 945 -4
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 38 buys · 12 sells
| Name | Role | Stake |
|---|---|---|
| Gerard Fasano | Group President of Defense Group | 0.08% |
| Harry M. Kraemer | Independent Director | 0.07% |
| Noel Geer | Independent Director | 0.05% |
| Mary Schmanske | Executive VP of Corporate Operations & Chief Corporate Operations Officer | 0.05% |
| Robert Shapard | Independent Chairperson | 0.05% |
| Christopher Cage | Chief Financial Officer | 0.05% |
| Roy Stevens | President of the Intelligence Group | 0.04% |
| Thomas Bell | Chief Executive Officer | 0.04% |
| Elizabeth A. Porter | President of Health Group | 0.04% |
| Steve Hull | Former Chief Information Officer | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Robert Shapard | Independent Chairperson | Other Acquisition | +5 | -- |
| 2026-09-29 | Harry M. Kraemer | Independent Director | Other Acquisition | +463 | -- |
| 2026-09-29 | Daniel Antal | Former Corporate Secretary | Other Acquisition | +4 | -- |
| 2026-09-29 | Roy Stevens | President of the Intelligence Group | Other Acquisition | +6 | -- |
| 2026-09-29 | Christopher Cage | Chief Financial Officer | Other Acquisition | +92 | -- |
| 2026-08-31 | Gary May | Independent Director | Open Market Disposition | -1,000 | $140.85 |
| 2026-08-10 | Noel Geer | Independent Director | Open Market Disposition | -10,000 | $140.59–141.07 |
| 2026-08-03 | Roy Stevens | President of the Intelligence Group | Sale to Issuer | -4,584 | $118.72 |
| 2026-08-03 | Christopher Cage | Chief Financial Officer | Sale to Issuer | -4,584 | $118.72 |
| 2026-08-03 | Elizabeth A. Porter | President of Health Group | Sale to Issuer | -5,092 | $118.72 |
| 2026-07-05 | Harry M. Kraemer | Independent Director | Other Acquisition | +310 | -- |
| 2026-06-29 | Robert Shapard | Independent Chairperson | Other Acquisition | +6 | -- |
| 2026-06-29 | Harry M. Kraemer | Independent Director | Other Acquisition | +565 | -- |
| 2026-06-29 | Daniel Antal | Former Corporate Secretary | Other Acquisition | +5 | -- |
| 2026-06-29 | Roy Stevens | President of the Intelligence Group | Other Acquisition | +7 | -- |
| 2026-06-29 | Christopher Cage | Chief Financial Officer | Other Acquisition | +113 | -- |
| 2026-05-07 | Noel Geer | Independent Director | Other Acquisition | +1,067 | -- |
| 2026-05-07 | Noel Geer | Independent Director | Other Derivative Acquisition | +1,281 | $131.26 |
| 2026-05-07 | Robert Shapard | Independent Chairperson | Other Acquisition | +1,067 | -- |
| 2026-05-07 | Robert Shapard | Independent Chairperson | Other Derivative Acquisition | +1,281 | $131.26 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 06:06:35 · For reference only, not investment advice and not tailored to your situation.